Search

Communities across the nation often need more support and access to behavioral health providers. The U.S. Health Resources and Services Administration’s (HRSA) Bureau of Health…

Since 2016, Massachusetts has required long-term care facilities (LTCFs) to admit individuals requiring care who are also being treated with medication for opioid use disorder (MOUD). Failure to do so violates the Americans with Disabilities Act. While…

Abt provides technical assistance to stakeholders to advance methane mitigation and capture strategies across countries and sectors.

Improving outcomes for job seekers with low incomes remains a critical task for U.S. social policy. Over the past three decades, significant strides have been made to build evidence on programs to improve the economic stability of those with low incomes…

Abt supports new local partners in taking on incrementally larger roles in health system strengthening efforts.

As the opioid crisis and misuse of prescription drugs continue, the Substance Abuse and Mental Health Services Administration (SAMHSA) wants to ensure its investments in states, tribes, and their grantees created effective prevention programming to…

Abt Global has been awarded a seat on the Centers for Medicare & Medicaid Services’ (CMS) Research, Measurement, Assessment, Design, and Analysis 3 contract vehicle, known as RMADA 3.

Our work has helped address the supply of and demand for illegal drugs and the misuse of legal substances for federal, state and local agencies, as well as other key stakeholders.

The Family and Medical Leave Act (FMLA) guarantees eligible U.S. employees of covered employers job-protected unpaid leave to attend to their or their family’s eligible medical issues. Employees may have access to pay while on leave through other means…